Induztr
Resumen técnico Visor de documentos Modelos relacionados

PowerPoint Presentation

Technical Reference Summary

Covered Models & Document Scope

Póster #47D (MSACL 2018 US) que describe un método analítico rápido de LC/MS/MS con Regeneración de Columna Alterna (ACR) para el análisis de 125 fármacos y metabolitos en orina; desarrollado en un UHPLC Agilent 1290 Infinity II con espectrómetro de masas 6470 TQ; configuración ACR de dos columnas (Columna 1 / Columna 2, Agilent Poroshell 120 EC-C18, 2.1 x 10 mm); número de documento 5991-9141EN.

Technical Data

Parameter Value Condición
Analysis time (standard configuration) 7.35 min p.1 ↗ 5 min gradient + 1.5 min equilibration + 0.85 min injection
Analysis time (ACR configuration) 5.1 min p.1 ↗ injection to injection
Analysis time reduction with ACR 30 % p.1 ↗
Number of analytes 125 p.1 ↗
Eluent pump flow rate 0.35 mL/min p.1 ↗
Regeneration pump flow rate 0.5 mL/min p.1 ↗
Injection volume 10 µL p.1 ↗
Autosampler temperature 5 °C p.1 ↗
Column temperature 55 °C p.1 ↗
Column Agilent Poroshell 120 EC-C18, 2.1 x 10 mm p.1 ↗ Columns 2
Mobile phase A H2O + 5 mM Ammonium Formate + 0.01% Formic Acid p.1 ↗
Mobile phase B Methanol + 0.01% Formic Acid p.1 ↗
Needle wash 50:20:20:10 IPA:MeOH:ACN:H2O p.1 ↗
Gas temperature 300 °C p.1 ↗ positive mode
Gas temperature 300 °C p.1 ↗ negative mode
Gas flow 9 L/min p.1 ↗ positive mode
Gas flow 9 L/min p.1 ↗ negative mode
Nebulizer pressure 30 psi p.1 ↗ positive mode
Nebulizer pressure 30 psi p.1 ↗ negative mode
Sheath gas temperature 380 °C p.1 ↗ positive mode
Sheath gas temperature 380 °C p.1 ↗ negative mode
Sheath gas flow 11 L/min p.1 ↗ positive mode
Sheath gas flow 11 L/min p.1 ↗ negative mode
Capillary voltage 3750 V p.1 ↗ positive mode

Operating Limits

  • Calibration range: 1 to 1000 ng/mL p.1 ↗
  • Lowest analyzed concentration: 1 ng/mL (1 pg on column) p.1 ↗
  • Signal-to-noise at 1 ng/mL: better than 10 for 104 compounds p.1 ↗
  • Linearity range: 1 to 1000 ng/mL for 112 curves p.1 ↗
  • Reproducibility (CV): < 15% for majority of analytes p.1 ↗